345 related articles for article (PubMed ID: 20087968)
21. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
[TBL] [Abstract][Full Text] [Related]
22. [Relationship between serum hepatitis B virus DNA load and hepatocellular carcinoma in Qidong, China: a cohort follow-up study of 14 years].
Sun Y; Chen TY; Lu PX; Wang JB; Wu Y; Zhang QN; Qian GS; Tu H
Zhonghua Yi Xue Za Zhi; 2012 Jul; 92(27):1874-7. PubMed ID: 23134955
[TBL] [Abstract][Full Text] [Related]
23. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
Fattovich G; Pantalena M; Zagni I; Realdi G; Schalm SW; Christensen E;
Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564
[TBL] [Abstract][Full Text] [Related]
24. Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles.
Lee MH; Yang HI; Liu J; Batrla-Utermann R; Jen CL; Iloeje UH; Lu SN; You SL; Wang LY; Chen CJ;
Hepatology; 2013 Aug; 58(2):546-54. PubMed ID: 23504622
[TBL] [Abstract][Full Text] [Related]
25. Delayed clearance of serum HBsAg in compensated cirrhosis B: relation to interferon alpha therapy and disease prognosis. European Concerted Action on Viral Hepatitis (EUROHEP).
Fattovich G; Giustina G; Sanchez-Tapias J; Quero C; Mas A; Olivotto PG; Solinas A; Almasio P; Hadziyannis S; Degos F; de Moura MC; Krogsgaard K; Pantalena M; Realdi G; Corrocher R; Schalm SW
Am J Gastroenterol; 1998 Jun; 93(6):896-900. PubMed ID: 9647014
[TBL] [Abstract][Full Text] [Related]
26. [Hepatocellular carcinoma, hepatitis B virus and the immune system].
Grob PJ
Schweiz Med Wochenschr; 1986 Aug; 116(34):1133-45. PubMed ID: 3020684
[TBL] [Abstract][Full Text] [Related]
27. Common clinicopathological features of the patients with chronic hepatitis B virus infection who developed hepatocellular carcinoma after seroconversion to anti-HBs--a consideration of the pathogenesis of HBV-induced hepatocellular carcinoma and a strategy to inhibit it.
Tsuboi Y; Ohkoshi S; Yano M; Suzuki K; Tsubata SS; Ishihara K; Ichida T; Sugitani S; Shibazaki K; Aoyagi Y
Hepatogastroenterology; 2006; 53(67):110-4. PubMed ID: 16506387
[TBL] [Abstract][Full Text] [Related]
28. Natural history of chronic hepatitis B REVEALed.
Chen CJ; Yang HI
J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729
[TBL] [Abstract][Full Text] [Related]
29. Development of hepatocellular carcinoma after seroclearance of hepatitis B surface antigen.
Tong MJ; Nguyen MO; Tong LT; Blatt LM
Clin Gastroenterol Hepatol; 2009 Aug; 7(8):889-93. PubMed ID: 19394445
[TBL] [Abstract][Full Text] [Related]
30. Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis.
Huo TI; Wu JC; Lee PC; Chau GY; Lui WY; Tsay SH; Ting LT; Chang FY; Lee SD
Hepatology; 1998 Jul; 28(1):231-6. PubMed ID: 9657117
[TBL] [Abstract][Full Text] [Related]
31. Clearance of hepatitis B e antigen in patients with chronic hepatitis B and genotypes A, B, C, D, and F.
Livingston SE; Simonetti JP; Bulkow LR; Homan CE; Snowball MM; Cagle HH; Negus SE; McMahon BJ
Gastroenterology; 2007 Nov; 133(5):1452-7. PubMed ID: 17920063
[TBL] [Abstract][Full Text] [Related]
32. Nested case-control study: hepatocellular carcinoma risk after hepatitis B surface antigen seroclearance.
Gounder PP; Bulkow LR; Snowball M; Negus S; Spradling PR; Simons BC; McMahon BJ
Aliment Pharmacol Ther; 2016 Jun; 43(11):1197-207. PubMed ID: 27061300
[TBL] [Abstract][Full Text] [Related]
33. What can we learn from hepatitis B virus clinical cohorts?
Lin CL; Tseng TC; Kao JH
Liver Int; 2015 Jan; 35 Suppl 1():91-9. PubMed ID: 25529093
[TBL] [Abstract][Full Text] [Related]
34. Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients.
Squadrito G; Pollicino T; Cacciola I; Caccamo G; Villari D; La Masa T; Restuccia T; Cucinotta E; Scisca C; Magazzu D; Raimondo G
Cancer; 2006 Mar; 106(6):1326-30. PubMed ID: 16453330
[TBL] [Abstract][Full Text] [Related]
35. High levels of hepatitis B surface antigen are associated with poorer survival and early recurrence of hepatocellular carcinoma in patients with low hepatitis B viral loads.
Liu WR; Tian MX; Jin L; Yang LX; Ding ZB; Shen YH; Peng YF; Zhou J; Qiu SJ; Dai Z; Fan J; Shi YH
Ann Surg Oncol; 2015 Mar; 22(3):843-50. PubMed ID: 25269529
[TBL] [Abstract][Full Text] [Related]
36. [The discrepancy of HBsAg titre and HBV DNA in patients with chronic hepatitis B, HBV-related liver cirrhosis and hepatocellular carcinoma].
Pei YZ; Han T; Ma XY; Li Y; Xing J; Song ZL
Zhonghua Gan Zang Bing Za Zhi; 2011 Oct; 19(10):743-6. PubMed ID: 22409845
[TBL] [Abstract][Full Text] [Related]
37. Systematic review with meta-analysis: development of hepatocellular carcinoma in chronic hepatitis B patients with hepatitis B surface antigen seroclearance.
Liu F; Wang XW; Chen L; Hu P; Ren H; Hu HD
Aliment Pharmacol Ther; 2016 Jun; 43(12):1253-61. PubMed ID: 27117732
[TBL] [Abstract][Full Text] [Related]
38. Transplantation of hepatitis B surface antigen-positive livers into hepatitis B virus-positive recipients and the role of hepatitis delta coinfection.
Franchello A; Ghisetti V; Marzano A; Romagnoli R; Salizzoni M
Liver Transpl; 2005 Aug; 11(8):922-8. PubMed ID: 16035057
[TBL] [Abstract][Full Text] [Related]
39. Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B.
Wong GL; Chan HL; Wong CK; Leung C; Chan CY; Ho PP; Chung VC; Chan ZC; Tse YK; Chim AM; Lau TK; Wong VW
J Hepatol; 2014 Feb; 60(2):339-45. PubMed ID: 24128413
[TBL] [Abstract][Full Text] [Related]
40. Serum hepatitis B surface antigen correlates with tissue covalently closed circular DNA in patients with hepatitis B-associated hepatocellular carcinoma.
Wang Q; Luan W; Warren L; Fiel MI; Blank S; Kadri H; Tuvin D; Hiotis SP
J Med Virol; 2016 Feb; 88(2):244-51. PubMed ID: 26174662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
